Researchers discuss vaccine development, continued efforts on novel coronavirus

A researcher at Protein Sciences works in a lab
A researcher at Protein Sciences works in a lab on March 12 in Meriden, Conn. The biotech company is currently researching a vaccine for COVID-19.
Jessica Hill | AP

This week, a vaccine candidate for the novel coronavirus hit a new milestone and entered the second phase of clinical trials. But what does that mean in terms of how soon this vaccine — or others — might be ready for public use? 

This vaccine is far from the only trial under way, with researchers around the world racing to safely produce a product — or products — to protect against COVID-19 infection.

Join Kerri Miller on our weekly show focusing on the science of the novel coronavirus as she talks with two researchers about how the vaccine development process works and the speed of the science happening during a pandemic. We’ll also answer your questions.


To listen to the full conversation you can use the audio player above.

Subscribe to the MPR News with Kerri Miller podcast on: Apple Podcasts, Google Podcasts , Spotify or RSS

Before you go...

MPR News is dedicated to bringing you clarity in coverage from our reporters across the state, stories that connect us, and conversations that provide perspectives when we need it most. We rely on your help to do this. Your donation has the power to keep MPR News strong and accessible to all during this crisis and beyond.